keyword
MENU ▼
Read by QxMD icon Read
search

chemoperfusion

keyword
https://www.readbyqxmd.com/read/28628712/hyperthermic-intraperitoneal-chemoperfusion-as-a-component-of-multimodality-therapy-for-ovarian-and-primary-peritoneal-cancer
#1
Deepa Magge, Lekshmi Ramalingam, Yongli Shuai, Robert P Edwards, James F Pingpank, Steven S Ahrendt, Matthew P Holtzman, Herbert J Zeh, David L Bartlett, Haroon A Choudry
BACKGROUND AND OBJECTIVES: The role of hyperthermic intraperitoneal chemoperfusion (HIPEC) in the multimodality treatment of ovarian peritoneal metastases (OPM) and primary peritoneal cancer (PPC) remains controversial. We hypothesized that cytoreductive surgery (CRS) and HIPEC would provide meaningful survival benefit without excessive morbidity. METHODS: We reviewed clinicopathologic and perioperative data following 96 CRS-HIPEC procedures for primary or recurrent OPM and PPC...
June 19, 2017: Journal of Surgical Oncology
https://www.readbyqxmd.com/read/28540828/tumor-tissue-transport-after-intraperitoneal-anticancer-drug-delivery
#2
Charlotte Carlier, Ada Mathys, Emiel De Jaeghere, Margo Steuperaert, Olivier De Wever, Wim Ceelen
Intraperitoneal (IP) drug delivery, either as an intraoperative chemoperfusion or as adjuvant, repeated instillation, is an established treatment modality in patients with peritoneal carcinomatosis. The efficacy of IP drugs depends on its ability to penetrate the tumor stroma in order to reach their (sub)cellular target. It is known, that drug penetration after IP delivery is limited to a few millimeters. Here, we review the basic tissue transport mechanisms after IP delivery, and discuss the biophysical barriers and obstacles that limit penetration distance...
March 28, 2017: International Journal of Hyperthermia
https://www.readbyqxmd.com/read/28291907/the-effects-of-hyperthermic-intraperitoneal-chemoperfusion-on-colonic-anastomosis-an-experimental-study-in-a-rat-model
#3
Afag Aghayeva, Cigdem Benlice, Ismail Ahmet Bilgin, Pinar Atukeren, Gulen Dogusoy, Figen Demir, Deniz Atasoy, Bilgi Baca
INTRODUCTION: Cytoreductive surgery (CRS) with subsequent hyperthermic intraperitoneal chemotherapy (HIPEC) is a promising modality to treat and prevent peritoneal metastases. However, this treatment is associated with signficant morbidity and mortality. Whether or not CRS with HIPEC interferes with anastomotic healing has also been debated. This study was designed to investigate the effects of mitomycin C, cisplatin, oxaliplatin, and doxorubicin used in HIPEC treatment on colonic anastomosis healing in a rat model...
May 12, 2017: Tumori
https://www.readbyqxmd.com/read/27995449/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemoperfusion-in-adolescent-and-young-adults-with-peritoneal-metastases
#4
Mashaal Dhir, Lekshmi Ramalingam, Yongli Shuai, Sam Pakrafter, Heather L Jones, Melissa E Hogg, Amer H Zureikat, Matthew P Holtzman, Steven A Ahrendt, Nathan Bahary, James F Pingpank, Herbert J Zeh, David L Bartlett, Haroon A Choudry
BACKGROUND: Several studies suggest that young patients may derive less oncologic benefit from surgical resection of cancers compared with older patients. We hypothesized that young patients may have worse outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion (CRS/HIPEC) for peritoneal metastases. METHODS: Perioperative and oncologic outcomes in adolescent and young adults (AYA), defined as younger than age 40 years (n = 135), undergoing CRS/HIPEC between 2001 and 2015 were reviewed and compared with middle-aged adults, defined as aged 40-65 years (n = 684)...
December 19, 2016: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/27830163/dual-energy-ct-of-liver-metastases-in-patients-with-uveal-melanoma
#5
Jens Altenbernd, Axel Wetter, Michael Forsting, Lale Umutlu
OBJECTIVE: To investigate the value of different kVp images of dual-energy CT (DECT) for the detection of liver metastases. METHODS: 20 Patients with uveal melanoma were investigated with DECT of the liver. In each patient contrast-enhanced DECT imaging with arterial delay was performed. Number and size of metastases were documented on arterial phase 80-kVp images, virtual 120-kVp images and following angiographic images (DSA) as part of hepatic chemoperfusion. Attenuation of metastases and several anatomic regions, subjective (image noise, image quality) and objective (SNR, CNR) parameters were documented...
2016: European Journal of Radiology Open
https://www.readbyqxmd.com/read/27611097/nanoscopic-tumor-tissue-distribution-of-platinum-after-intraperitoneal-administration-in-a-xenograft-model-of-ovarian-cancer
#6
Charlotte Carlier, Brecht Laforce, Stijn J M Van Malderen, Félix Gremonprez, Remi Tucoulou, Julie Villanova, Olivier De Wever, Laszlo Vincze, Frank Vanhaecke, Wim Ceelen
There is increasing interest in the treatment of advanced stage ovarian cancer (OC) using intraperitoneal (IP) delivery of platinum (Pt)-based chemotherapy. The antitumor efficacy of IP chemotherapy is determined by efficient tumor tissue penetration. Although it is assumed that Pt penetration is limited to a few millimeters after IP delivery, little is known on the distribution of Pt in different tumor compartments at the ultrastructural level following IP administration. Here, using synchrotron radiation X-ray fluorescence spectrometry (SR-XRF) and laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS), Pt distribution and penetration in OC peritoneal xenografts were determined at nanometer scale after IP chemoperfusion of cisplatin at 37-38°C or 40-41°C (hyperthermic)...
November 30, 2016: Journal of Pharmaceutical and Biomedical Analysis
https://www.readbyqxmd.com/read/27530056/the-current-status-of-immunotherapy-in-peritoneal-carcinomatosis
#7
REVIEW
Michael Alfred Ströhlein, Markus Maria Heiss, Karl-Walter Jauch
INTRODUCTION: Peritoneal carcinomatosis (PC) is a cancer disease with an urgent need for effective treatment. Conventional chemotherapy failed to show acceptable results. Cytoreductive surgery and hyperthermic chemoperfusion (HIPEC) are only beneficial in few patients with resectable peritoneal metastasis. Immunotherapy could be attractive against PC, as all requirements for immunotherapy are available in the peritoneal cavity. AREAS COVERED: This review analyzes the present literature for immunotherapy of PC...
October 2016: Expert Review of Anticancer Therapy
https://www.readbyqxmd.com/read/27506661/effects-of-neoadjuvant-laparoscopic-hyperthermic-intraperitoneal-chemotherapy-and-neoadjuvant-intraperitoneal-systemic-chemotherapy-on-peritoneal-metastases-from-gastric-cancer
#8
Yutaka Yonemura, Haruaki Ishibashi, Masamitu Hirano, Akiyoshi Mizumoto, Kazuyosi Takeshita, Kousuke Noguchi, Nobuyuki Takao, Masumi Ichinose, Yang Liu, Yan Li
BACKGROUND: The Peritoneal Cancer Index (PCI) is the most important prognostic factor following comprehensive treatment for peritoneal metastasis (PM) from gastric cancer (GCPM); however, 70 % of patients with GCPM showed a PCI score above the cut-off level at the time of diagnosis. Furthermore, neoadjuvant chemotherapy may reduce the PCI score to lower than the cut-off levels. In this study, the effects of neoadjuvant laparoscopic hyperthermic intraperitoneal chemoperfusion (NLHIPEC) and neoadjuvant intraperitoneal/systemic chemotherapy (NIPS) were investigated...
February 2017: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/27401448/curative-surgical-resection-as-a-component-of-multimodality-therapy-for-peritoneal-metastases-from-goblet-cell-carcinoids
#9
Michal Radomski, Reetesh K Pai, Yongli Shuai, Lekshmi Ramalingam, Heather Jones, Matthew P Holtzman, Steven A Ahrendt, James F Pingpank, Herbert J Zeh, David L Bartlett, Haroon A Choudry
BACKGROUND: The impact of histopathologic features on oncologic outcomes for patients with peritoneal metastases from goblet cell carcinoid (GCC) undergoing multimodality therapy, including cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion (CRS-HIPEC), is unknown. METHODS: This study prospectively analyzed 43 patients with GCC undergoing CRS-HIPEC between 2005 and 2013. Pathology slides were re-reviewed to classify GCC into histologic subtypes according to the Tang classification...
July 11, 2016: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/27362668/cytoreductive-surgery-combined-with-hyperthermic-intraperitoneal-chemoperfusion-for-the-treatment-of-gastric-cancer-a-single-centre-retrospective-study
#10
Yinuo Tu, Yunhong Tian, Zhiyuan Fang, Qiang Ruan, Hongsheng Tang, Xiangliang Zhang, Yinbing Wu, Yan Ding, Shuzhong Cui
AIM: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemoperfusion (HIPEC) is the treatment regime most likely to achieve prolonged survival in patients with peritoneal carcinomatosis from gastroenteric cancer. To date, few publications have focused on the treatment of patients with gastric cancer alone. Several controversies remain unsolved, including the safety and effectiveness of the CRS-HIPEC combination regime, particularly in cases where HIPEC is used as adjuvant treatment after CRS...
September 2016: International Journal of Hyperthermia
https://www.readbyqxmd.com/read/27271716/-hyperthermic-intraperitoneal-chemotherapy-combined-with-cytoreductive-procedure-in-patients-with-peritoneal-pseudomyxoma
#11
G I Gafton, K Yu Senchik, G S Kireeva, V G Petrov, V V Semiglazov, K D Guseynov, V G Bespalov, O A Belyaeva, A M Belyaev
AIM: To study the results of intraperitoneal chemoperfusion combined with cytoreductive procedure in patients with peritoneal pseudomyxoma. MATERIAL AND METHODS: For the period 2006--2015 seven patients with peritoneal pseudomyxoma underwent aggressive treatment using hyperthermic intraperitoneal chemoperfusion combined with cytoreductive procedure at the Department of General Oncology of N.N. Petrov Research Institute of Oncology. RESULTS: Two patients had postoperative complications...
2016: Khirurgiia
https://www.readbyqxmd.com/read/27268626/aggressive-treatment-of-performance-status-1-and-2-hcc-patients-significantly-improves-survival-an-egyptian-retrospective-cohort-study-of-524-cases
#12
COMPARATIVE STUDY
Ashraf Omar Abdel Aziz, Dalia Omran, Mohamed Mahmoud Nabeel, Tamer Mahmoud Elbaz, Ahmed Hosni Abdelmaksoud, Inas El Attar, Hend Ibrahim Shousha
BACKGROUND: In the Barcelona Clinic Liver Cancer (BCLC) system, only sorafenib is suggested for HCC patients having performance status (PS) 1 or 2 even if they have treatable lesions. In the current study, we aimed to explore the outcome of using aggressive treatment for HCC patients with PS 1 and 2. MATERIALS AND METHODS: Five hundred and twenty four patients with HCC were enrolled in this study and divided into 2 groups: 404 PS 1 and 120 PS 2. Of the included 524 patients, 136 recceived non-aggressive supportive treatment and sorafenib, while 388 patients were offered aggressive treatment in the form of surgical resection, transplantation, percutaneous ablation, trans-arterial chemoembolization and/or chemoperfusion...
2016: Asian Pacific Journal of Cancer Prevention: APJCP
https://www.readbyqxmd.com/read/27160355/a-comprehensive-treatment-for-peritoneal-metastases-from-gastric-cancer-with-curative-intent
#13
REVIEW
Y Yonemura, E Canbay, Y Li, F Coccolini, O Glehen, P H Sugarbaker, D Morris, B Moran, S Gonzaletz-Moreno, M Deraco, P Piso, D Elias, D Batlett, H Ishibashi, A Mizumoto, V Verwaal, H Mahtem
Recently, Peritoneal Surface Oncology Group International (PSOGI) developed a novel comprehensive treatment consisting of cytoreductive surgery (CRS) and perioperative chemotherapy (POC) for the treatment of peritoneal metastases (PM) from gastric cancer with curative intent. This article reviews the results of this treatment and verifies its indication. In this strategy, peritoneal cancer index (PCI) is determined by laparoscopy, and a peritoneal port is placed. Neoadjuvant bidirectional intraperitoneal/systemic chemotherapy (NIPS) is performed for 3 cycles, and then laparotomy is performed...
August 2016: European Journal of Surgical Oncology
https://www.readbyqxmd.com/read/27046514/feasibility-of-assessing-pulmonary-blood-volume-using-c-arm-ct-during-transpulmonary-chemoperfusion-and-chemoembolization-in-primary-and-secondary-lung-tumours
#14
Thomas J Vogl, Nour-Eldin A Nour-Eldin, Nagy N N Naguib, Thomas Lehnert, Hanns Ackermann, Renate Hammerstingl, Marcus Hezel
OBJECTIVE: Assessment of parenchymal blood volume (PBV) of primary and secondary pulmonary malignancies by using a C-arm CT, regarding its role in detecting early functional response to transpulmonary chemoembolization (TPCE) and clinical practicability. METHODS: 21 patients with a mean age of 56.77 years, who were assigned to TPCE during their palliative treatment, were included. PBV and the diameter of tumours were analyzed. PBV maps were calculated from three-dimensional CT-angiographic (3D-CTA) data sets...
June 2016: British Journal of Radiology
https://www.readbyqxmd.com/read/27027310/intrathoracic-chemoperfusion-decreases-recurrences-in-patients-with-full-thickness-diaphragm-involvement-with-mucinous-appendiceal-adenocarcinoma
#15
Travis E Grotz, Paul F Mansfield, Richard E Royal, Gary N Mann, Safia Rafeeq, Karen A Beaty, Michael J Overman, Keith F Fournier
BACKGROUND: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) is the preferred treatment for selected patients with mucinous appendiceal adenocarcinoma. Frequently, the hemidiaphragms are infiltrated with tumor, requiring partial diaphragm resection (DR) in order to obtain complete cytoreduction (CC-0). The clinical significance of diaphragmatic invasion and the optimum management to prevent transmission of disease from abdomen to chest is largely unknown. METHODS: This was a retrospective review of 78 patients with mucinous appendiceal adenocarcinoma undergoing cytoreduction and partial DR at a single institution between 2010 and 2014...
September 2016: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/26941990/impact-of-surgical-volume-of-centers-on-post-operative-outcomes-from-cytoreductive-surgery-and-hyperthermic-intra-peritoneal-chemoperfusion
#16
REVIEW
Rahul Rajeev, Brittany Klooster, Kiran K Turaga
Complex surgical operations performed at centers of high volume have improved outcomes due to improved surgical proficiency, and betters systems of care including avoidance of errors. Cytoreductive surgery (CRS) and hyperthermic intra-peritoneal chemoperfusion (HIPEC), which has been shown to be an oncologically effective strategy for peritoneal carcinomatosis (PC), is one such procedure with significant morbidity and mortality. The learning curve to reach technical proficiency in CRS + HIPEC is about 140-220 cases for a center...
February 2016: Journal of Gastrointestinal Oncology
https://www.readbyqxmd.com/read/26941989/palliative-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemoperfusion-current-clinical-practice-or-misnomer
#17
REVIEW
Laura A Lambert, Ariana Harris
Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (CRS/HIPEC) is being used more and more frequently for the management of peritoneal carcinomatosis. Despite significant improvements in oncologic outcomes and the risk of complications and mortality, CRS/HIPEC remains one of the most morbid treatments offered for advanced cancers. Consequently CRS/HIPEC is still considered controversial by many, even in the setting of cancers that are potentially curable. However, as high volume surgical oncologists become more experienced with CRS/HIPEC, the potential role of "palliative CRS/HIPEC" in the management of peritoneal carcinomatosis is being raised...
February 2016: Journal of Gastrointestinal Oncology
https://www.readbyqxmd.com/read/26889144/how-effective-are-percutaneous-liver-directed-therapies-in-patients-with-non-colorectal-liver-metastases
#18
REVIEW
Thomas J Vogl, Ahmed Emam, Nagy N Naguib, Katrin Eichler, Stefan Zangos
BACKGROUND: The purpose of this review is to demonstrate the clinical indications, technical developments, and outcome of liver-directed therapies in interventional oncology of non-colorectal liver metastases. METHODS: Liver-directed therapies are classified into vascular transarterial techniques such as chemoperfusion (TACP), chemoembolization (TACE), radioembolization (selective internal radiation therapy (SIRT)), and chemosaturation, as well as thermal ablation techniques like microwave ablation (MWA), radiofrequency ablation (RFA), laser-induced thermotherapy (LITT), cryotherapy, and irreversible electroporation (IRE)...
December 2015: Viszeralmedizin
https://www.readbyqxmd.com/read/26817759/novel-software-assisted-hemodynamic-evaluation-of-pelvic-flow-during-chemoperfusion-of-pelvic-arteries-for-bladder-cancer-double-versus-single-balloon-technique
#19
Kiyohito Yamamoto, Kazuhiro Yamamoto, Go Nakai, Haruhito Azuma, Yoshifumi Narumi
PURPOSE: Approximately 83 % of patients with bladder cancer have achieved a complete response after undergoing a novel bladder preservation therapy involving balloon-occluded intra-arterial infusion chemotherapy (BOAI) using a four-lumen double-balloon catheter, known as the Osaka Medical College regimen. This study aimed to show the quantitative difference in hemodynamics of the bladder arteries using syngo iFlow (Siemens Healthcare, Erlangen, Germany), which provides an automatic tool for quantitative blood flow analysis between double BOAI (D-BOAI) and conventional single BOAI (S-BOAI)...
June 2016: Cardiovascular and Interventional Radiology
https://www.readbyqxmd.com/read/26774152/clinical-efficacy-of-type-b-ultrasound-guided-intraperitoneal-hyperthermic-chemoperfusion-combined-with-systemic-chemotherapy-in-advanced-gastric-cancer-patients-with-malignant-ascites
#20
C Lu, L Li, Z Luo, Y Cui, P Fu, J Zhou, N Ma, Y Zhou
OBJECTIVES: To evaluate the clinical efficacy of systemic chemotherapy combined with intraperitoneal hyperthermic perfusion in advanced gastric cancer patients with malignant ascites. PATIENTS AND METHODS: Forty-eight gastric cancer patients with malignant ascites who were admitted to our hospital were selected and randomly divided into the hyperthermic perfusion and control groups. The control group only received systemic chemotherapy, and the hyperthermic perfusion group received systemic chemotherapy combined with intraperitoneal hyperthermic chemoperfusion...
2016: Neoplasma
keyword
keyword
44720
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"